In addition, EIF4A3 was found highly expressed in many cancers, such as prostate cancer (29), bladder cancer (30), endometrial cancer (31), so EIF4A3 may be an oncogene in cancer. This evidence concerns the gene EIF4A3 and urinary bladder cancer.